BACKGROUND AND AIMS: Obesity is associated with a blunted beta-adrenoceptor-mediated lipolysis and fat oxidation. We investigated whether polymorphisms in codon 16, 27 and 164 of the beta (2)-adrenoceptor gene (ADRB2) and exon 10 of the G protein beta (3)-subunit gene (GNB3) are associated with alterations in in vivo lipolysis and fat oxidation. DESIGN AND METHODS: Sixty-five male and 43 female overweight and obese subjects (body mass index (BMI) range: 26.1-48.4 kg/m(2)) were included. Energy expenditure (EE), respiratory quotient (RQ), circulating free fatty acid (FFA) and glycerol levels were determined after stepwise infusion of increasing doses of the non-selective beta-agonist isoprenaline (ISO). RESULTS: In women, the Arg16 allele of the ADRB2 gene was associated with a blunted increase in circulating FFA, glycerol and a decreased fat oxidation during ISO stimulation. In men, the Arg16 allele was significantly associated with a blunted increase in FFA but not in glycerol or fat oxidation. CONCLUSION: These results suggest that genetic variation in the ADRB2 gene is associated with disturbances in in vivo beta-adrenoceptor-mediated lipolysis and fat oxidation during beta-adrenergic stimulation in overweight and obese subjects; these effects are influenced by gene-gender interactions.
BACKGROUND AND AIMS: Obesity is associated with a blunted beta-adrenoceptor-mediated lipolysis and fat oxidation. We investigated whether polymorphisms in codon 16, 27 and 164 of the beta (2)-adrenoceptor gene (ADRB2) and exon 10 of the G protein beta (3)-subunit gene (GNB3) are associated with alterations in in vivo lipolysis and fat oxidation. DESIGN AND METHODS: Sixty-five male and 43 female overweight and obese subjects (body mass index (BMI) range: 26.1-48.4 kg/m(2)) were included. Energy expenditure (EE), respiratory quotient (RQ), circulating free fatty acid (FFA) and glycerol levels were determined after stepwise infusion of increasing doses of the non-selective beta-agonist isoprenaline (ISO). RESULTS: In women, the Arg16 allele of the ADRB2 gene was associated with a blunted increase in circulating FFA, glycerol and a decreased fat oxidation during ISO stimulation. In men, the Arg16 allele was significantly associated with a blunted increase in FFA but not in glycerol or fat oxidation. CONCLUSION: These results suggest that genetic variation in the ADRB2 gene is associated with disturbances in in vivo beta-adrenoceptor-mediated lipolysis and fat oxidation during beta-adrenergic stimulation in overweight and obese subjects; these effects are influenced by gene-gender interactions.
Authors: Gustavo W Fernandes; Cintia B Ueta; Tatiane L Fonseca; Cecilia H A Gouveia; Carmen L Lancellotti; Patrícia C Brum; Marcelo A Christoffolete; Antonio C Bianco; Miriam O Ribeiro Journal: J Endocrinol Date: 2014-06 Impact factor: 4.286
Authors: Sarah J Lessard; Donato A Rivas; Zhi-Ping Chen; Bryce J van Denderen; Matthew J Watt; Lauren G Koch; Steven L Britton; Bruce E Kemp; John A Hawley Journal: Endocrinology Date: 2009-10-09 Impact factor: 4.736
Authors: Hannah C Cox; Claire Bellis; Rod A Lea; Sharon Quinlan; Roger Hughes; Thomas Dyer; Jac Charlesworth; John Blangero; Lyn R Griffiths Journal: Hum Hered Date: 2009-04-01 Impact factor: 0.444
Authors: Giovanna Mantovani; Sara Bondioni; Luisella Alberti; Luisa Gilardini; Cecilia Invitti; Sabrina Corbetta; Marco A Zappa; Stefano Ferrero; Andrea G Lania; Silvano Bosari; Paolo Beck-Peccoz; Anna Spada Journal: Diabetes Date: 2008-12-18 Impact factor: 9.461